Showing results (261-270 of 887) with videos related to
Sort By:
Pageof 89
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|July 1, 2021
Potential role of hepatic lipase in the accretion of docosahexaenoic acid (DHA) by the brainDhavamani Sugasini, Peng Yang, Dominic Ng, et al.Journal of Lipid Research|October 26, 2010
Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDLJohn S Millar, Katsunori Ikewaki, LeAnne T Bloedon, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 25, 2014
Role of SN1 lipases on plasma lipids in metabolic syndrome and obesityVerónica Miksztowicz, Laura Schreier, Mary McCoy, et al.Elife|April 26, 2021
A Mendelian randomization study of the role of lipoprotein subfractions in coronary artery diseaseQingyuan Zhao, Jingshu Wang, Zhen Miao, et al.Circulation|June 11, 2003
Expression of human hepatic lipase in the rabbit model preferentially enhances the clearance of triglyceride-enriched versus native high-density lipoprotein apolipoprotein A-IShirya Rashid, Denny K Trinh, Kristine D Uffelman, et al.Atherosclerosis|November 8, 2008
Effects of nevirapine and efavirenz on HDL cholesterol levels and reverse cholesterol transport in miceJunichiro Tohyama, Jeffrey T Billheimer, Ilia V Fuki, et al.Annals of Internal Medicine|June 17, 2009
Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trialDavid J Becker, Ram Y Gordon, Steven C Halbert, et al.Journal of Lipid Research|January 22, 2022
A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiencyCecilia Vitali, Archna Bajaj, Christina Nguyen, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 29, 2011
Peroxisome proliferator-activated receptor-α activation promotes macrophage reverse cholesterol transport through a liver X receptor-dependent pathwayKazuhiro Nakaya, Junichiro Tohyama, Snehal U Naik, et al.The American Journal of Cardiology|June 30, 2015
On-Statin Resistin, Leptin, and Risk of Recurrent Coronary Events After Hospitalization for an Acute Coronary Syndrome (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Study)Amit V Khera, Arman Qamar, Sabina A Murphy, et al.Pageof 89